The Patent Finder

Keyneurotek Pharmaceuticals AG

Also on record
Records under this name other than patents Keyneurotek Pharmaceuticals AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Keyneurotek Pharmaceuticals AG

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,670,576Device and method for measuring impedance in organotypic tissues
Formerly held
Lapsed on the fee record
Ended Jun 2, 2024 · USPTO record
Lapsed on the fee recordEnded Jun 2, 2024USPTO record
US 8,263,636Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases
Lapsed on the fee record
Ended Sep 11, 2016 · USPTO record
Lapsed on the fee recordEnded Sep 11, 2016USPTO record
US 7,291,599Use of inhibitors of enzymes having activities of amino peptidase N and/or dipeptidyl peptidase IV and of pharmaceutical preparations thereof for a therapy and prevention of chronical neurodegenerative diseases
Formerly held
Lapsed on the fee record
Ended Nov 6, 2015 · USPTO record
Lapsed on the fee recordEnded Nov 6, 2015USPTO record
US 7,858,655Drug preparation comprising α-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases
Lapsed on the fee record
Ended Dec 28, 2014 · USPTO record
Lapsed on the fee recordEnded Dec 28, 2014USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited